Jfs Wealth Advisors, LLC Astrazeneca PLC Transaction History
Jfs Wealth Advisors, LLC
- $1.49 Billion
- Q3 2024
A detailed history of Jfs Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Jfs Wealth Advisors, LLC holds 2,372 shares of AZN stock, worth $165,067. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,372
Previous 2,316
2.42%
Holding current value
$165,067
Previous $180,000
2.22%
% of portfolio
0.01%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding AZN
# of Institutions
1,342Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.38 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.92 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.59 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.56 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.33 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $216B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...